Nanosecond Pulsed Field Ablation in the Management of Benign Thyroid Nodules
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorM.D. Anderson Cancer Center
About this trial
To observe the outcomes of nsPFA therapy to treat benign thyroid nodules.
Eligibility criteria
Qualifiers
Scheduled to undergo ultrasound guided nsPFA as standard of care
Age 18 to 80 years.
Capable of providing independent consent.
Benign FNA X 2 or
Disqualifiers
Age <18
Patients considered unsuitable for nsPFA by the treating physician
Trial design
Treatments tested in this trial
- Questionnaire
Treatment groups
No treatment groups listed
Locations
1MD Anderson Cancer Center77030, HoustonTexas, United States
Sponsors and collaborators
M.D. Anderson Cancer Center
Lead sponsor
Source ClinicalTrials.gov